CF PharmTech, Inc. (HKG:2652)
Hong Kong · Delayed Price · Currency is HKD 21.70
-0.76 (-3.38%)
At close: Apr 29, 2026
CF PharmTech Market Cap
CF PharmTech has a market cap or net worth of 9.24 billion as of April 29, 2026.
Market Cap
9.24B
Enterprise Value
8.67B
Revenue
481.31M
Ranking
n/a
PE Ratio
3,340.95
Stock Price
21.70
Market Cap Chart
Since October 8, 2025, CF PharmTech's market cap has decreased from 15.86B to 9.24B, a decrease of -41.75%. That is a compound annual growth rate of -62.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 9.24B | -35.92% |
| Dec 31, 2025 | 14.42B | -9.11% |
| Oct 8, 2025 | 15.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CanSino Biologics | 12.90B |
| Xuanzhu Biopharmaceutical | 12.74B |
| Sihuan Pharmaceutical Holdings Group | 11.84B |
| Ab&B Bio-Tech CO., LTD. JS | 11.54B |
| Luye Pharma Group | 10.75B |
| Shandong Xinhua Pharmaceutical Company | 9.43B |
| China Traditional Chinese Medicine Holdings Co. | 8.41B |
| China Shineway Pharmaceutical Group | 7.39B |